A giant retail announcement increased investors’ appetite for a Canadian hemp stock Thursday. Here’s some small stocks making big moves on Thursday, December 13, 2018 (as of 11:30 am EST):
EastWest Bioscience (TSXV:EAST), a Canadian hemp stock, climbed 19% to $0.16 on Thursday after announcing that it is processing purchasing orders for its hemp-based consumer goods through global retailer The TJX Companies, Inc.
As well, shares of GT Gold Corp. (TSXV:GTT) slipped 8% to $0.60 as the junior explorer released assay results for four additional holes from its wholly-owned Tatogga property in British Columbia’s Golden Triangle, which included 117 metres of 0.83 g/t gold, 0.52% copper, and 1.39 g/t silver.
Carmanah Technologies Corporation (TSX:CMH), meanwhile, reported that it has agreed to sell a “significant” portion of its assets to SPX Corporation for US$77.0 million. Carmanah Technologies stock popped 74% to $5.92 following the announcement.
Finally, Relevium Technologies Inc. (TSXV:RLV) shares rose 14% to $0.12 after the health and wellness company announced that it has launched its Leefylyfe brand of organically sourced full spectrum hemp CBD products on a pre-order basis in the UK.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
EastWest Bioscience (TSXV:EAST), a Canadian hemp stock, climbed 19% to $0.16 on Thursday after announcing that it is processing purchasing orders for its hemp-based consumer goods through global retailer The TJX Companies, Inc.
